| Concurrent radiotherapy and ipilimumab immunotherapy for patients with melanoma CA Barker, MA Postow, SA Khan, K Beal, PK Parhar, Y Yamada, NY Lee, ... Cancer immunology research 1 (2), 92-98, 2013 | 157 | 2013 |
| Anal versus rectal melanoma: does site of origin predict outcome? DM Bello, E Smyth, D Perez, S Khan, LK Temple, CE Ariyan, MR Weiser, ... Diseases of the colon and rectum 56 (2), 150, 2013 | 88 | 2013 |
| Unstable angina associated with cisplatin and carboplatin in a patient with advanced melanoma S Khan, CL Chen, MS Brady, R Parameswaran, R Moore, H Hassoun, ... Journal of Clinical Oncology 30 (18), e163-e164, 2012 | 38 | 2012 |
| Novel Targets for the Treatment of Melanoma L Ambrosi, S Khan, RD Carvajal, J Yang Current oncology reports 21 (11), 97, 2019 | 25 | 2019 |
| Concurrent radiotherapy and ipilimumab immunotherapy for patients with melanoma. Cancer Immunol Res. 2013; 1 (2): 92–8. doi: 10.1158/2326-6066 CA Barker, MA Postow, SA Khan, K Beal, PK Parhar, Y Yamada, NY Lee, ... CIR-13-0082, 0 | 23 | |
| Ipilimumab in the treatment of uveal melanoma: The Memorial Sloan-Kettering Cancer Center experience. SA Khan, M Callahan, MA Postow, PB Chapman, GK Schwartz, ... Journal of Clinical Oncology 30 (15_suppl), 8549-8549, 2012 | 21 | 2012 |
| Targeted therapies in combination with immune therapies for the treatment of metastatic melanoma SA Christiansen, S Khan, GT Gibney The Cancer Journal 23 (1), 59-62, 2017 | 15 | 2017 |
| Antibody-Directed Therapies: Towards a Durable and Tolerable Treatment Platform for CTCL–A Review S Khan, A Sawas Frontiers in oncology 9, 645, 2019 | 10 | 2019 |
| Concurrent radiotherapy and ipilimumab immunotherapy for patients with melanoma. Cancer Immunol Res 2013; 1: 92-8; PMID: 24777500 CA Barker, MA Postow, SA Khan, K Beal, PK Parhar, Y Yamada, NY Lee, ... | 7 | |
| Mucosal melanoma: current strategies and future directions S Khan, RD Carvajal Expert Opinion on Orphan Drugs 7 (10), 427-434, 2019 | 3 | 2019 |
| Comparative molecular analyses of esophageal cancer: Adenocarcinoma vs. squamous cell carcinomas and impact on outcome. ME Salem, J Xiu, SA Khan, H Wang, BG Smaglo, WS El-Deiry, JJ Hwang, ... Journal of Clinical Oncology 34 (15_suppl), 4035-4035, 2016 | 3 | 2016 |
| O-005 Comparative molecular analyses of esophageal adenocarcinoma, esophageal squamous cell carcinoma, and gastric adenocarcinoma, and impact of molecular profile on outcome M Salem, J Xiu, W El-Deiry, S Reddy, P Philip, Z Gatalica, S Khan, ... Annals of Oncology 27 (suppl_2), ii119-ii119, 2016 | 2 | 2016 |
| Molecular Biology of Gastroesophageal Cancers: Opportunities and Challenges S Khan, S Mikhail, J Xiu, ME Salem Clinical advances in hematology & oncology: H&O 15 (1), 75-82, 2017 | | 2017 |
| Evaluating the Safety of Combined Ipilimumab and Radiotherapy for the Treatment of Metastatic Melanoma MA Postow, CA Barker, SA Khan, JD Wolchok JOURNAL OF IMMUNOTHERAPY 35 (9), 733-733, 2012 | | 2012 |
| Tolerance and Efficacy of Extracranial Radiation Therapy During Ipilimumab Immunotherapy for Metastatic Melanoma CA Barker, MA Postow, MK Callahan, S Khan, K Beal, PK Parhar, NY Lee, ... International Journal of Radiation Oncology• Biology• Physics 84 (3), S653-S654, 2012 | | 2012 |
| Our thanks to all those who have helped with this issue of Future Oncology. Listed below are authors, referees and others who have kindly given their time, effort and expertise … A Antonelli, H Azim, H Azim Jr, R Bartsch, M Baugh, M Brady, R Callahan, ... | | |
